← All diseases

Disease Atlas / Disease detail

Pulmonary fibrosis

This is an educational overview that conservatively summarizes the definition, causes, symptoms, diagnosis, management, and research evidence of pulmonary fibrosis.

pulmonary fibrosis · pulmonary interstitial fibrosis

MONDO:0002771Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · a0ff4ea8b206

Disease category
Pulmonary fibrosis is a category of diseases in which scarring occurs in the deep tissues of the lungs, causing them to gradually become thicker and stiffer, and is also referred to as pulmonary interstitial fibrosis.
Core mechanism
Environmental pollutants, certain medications, connective tissue diseases, and other interstitial lung diseases may be involved, and cases where no cause can be found are classified as idiopathic pulmonary fibrosis.
Main causes · related factors
It is understood that repetitive lung injury and abnormal wound healing cause the accumulation of fibrous tissue, which reduces the elasticity and oxygen exchange of the lungs.
Representative patterns
Representative features include progressively worsening shortness of breath and a persistent dry cough, which may be accompanied by fatigue and clubbing, where the tips of the fingers and toes become rounded and widened.
Individual differences
Risks and progression may vary depending on the cause, smoking, occupational/environmental exposure, comorbidities, age, and an individual's lung function.
Diagnosis
Symptoms often progress slowly, and unexplained weight loss, muscle/joint pain may appear, and blood oxygen levels may become insufficient.
Management
Diagnosis is made by comprehensively integrating chest imaging, pulmonary function tests, and lung biopsy if necessary, based on medical history and exposure assessment.
Treatment/Research Status
It may be difficult to confirm the cause and type through imaging or a single test alone, so differential diagnosis with infection, heart disease, and other interstitial lung diseases is required.
Read Evidence
Management aims to evaluate the cause and degree of progression and to reduce symptoms and function; exposure management and specialized respiratory care are important.
Key Precautions
Although there is currently no treatment to completely eliminate pulmonary fibrosis, medications, oxygen therapy, pulmonary rehabilitation, and lung transplantation may be used to improve symptoms and quality of life.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Pulmonary fibrosis is a category of diseases in which scarring occurs in the deep tissues of the lungs, causing them to gradually become thicker and stiffer, and is also referred to as pulmonary interstitial fibrosis.

Representative features include progressively worsening shortness of breath and a persistent dry cough, which may be accompanied by fatigue and clubbing, where the tips of the fingers and toes become rounded and widened.

How the disease works

Environmental pollutants, certain medications, connective tissue diseases, and other interstitial lung diseases may be involved, and cases where no cause can be found are classified as idiopathic pulmonary fibrosis.

It is understood that repetitive lung injury and abnormal wound healing cause the accumulation of fibrous tissue, which reduces the elasticity and oxygen exchange of the lungs.

Variations in presentation among individuals

Risks and progression may vary depending on the cause, smoking, occupational/environmental exposure, comorbidities, age, and an individual's lung function.

The broad framework of diagnosis and management

Symptoms often progress slowly, and unexplained weight loss, muscle/joint pain may appear, and blood oxygen levels may become insufficient.

Diagnosis is made by comprehensively integrating chest imaging, pulmonary function tests, and lung biopsy if necessary, based on medical history and exposure assessment.

Current status of treatment

It may be difficult to confirm the cause and type through imaging or a single test alone, so differential diagnosis with infection, heart disease, and other interstitial lung diseases is required.

Management aims to evaluate the cause and degree of progression and to reduce symptoms and function; exposure management and specialized respiratory care are important.

Although there is currently no treatment to completely eliminate pulmonary fibrosis, medications, oxygen therapy, pulmonary rehabilitation, and lung transplantation may be used to improve symptoms and quality of life.

How to read clinical trials

The registered study NCT06644144 is an observational study related to interstitial lung disease currently recruiting; the fact of registration alone cannot be used to determine treatment efficacy, approval, or whether it is standard care.

Points to verify during clinical consultations

In clinical practice, it is advisable to confirm changes in symptoms, oxygen use and activity limitations, smoking, occupational and drug exposure, presence of connective tissue disease, test results, and treatment goals.

Medical Guidance

This material is for educational purposes and is not intended as a guide for individual diagnosis or treatment. Please consult with medical professionals regarding symptoms and treatment decisions.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.